NCT05113888

Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome （IBS)

A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial of Qizhi Weitong Granules in the Treatment of Abdominal Pain Symptoms in Diarrhea-type Irritable Bowel Syndrome

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study are as follows: 1) To evaluate the efficacy and safety of Qizhi Weitong granules in the treatment of diarrhea-type irritable bowel syndrome (IBS-D);2) To explore the dosage of Qizhi Weitong Granulesin treatment of IBS-D.

Conditions

• Irritable Bowel Syndrome

Interventions

Type	Name	Description
DRUG	Qizhi weitong granules(High）	take orally before meals, 1 bag each time, 3 times a day.
DRUG	Qizhi weitong granules(Low）	take orally before meals, 1 bag each time, 3 times a day.
DRUG	Placebo	take orally before meals, 1 bag each time, 3 times a day.

Timeline

• Start date: 2021-12-01
• Primary completion: 2022-08-31
• Completion: 2022-12-31
• First posted: 2021-11-09
• Last updated: 2021-11-09